REGENXBIO Inc.

NASDAQ:RGNX

Biotechnology

Healthcare
$7.24 +1.97%

+$0.16 today

Market cap
$478.73M
Beta
1.03
P/E (TTM)
-1.5
EPS (TTM)
-$5.53
52W Low $5.46High $16.19

Volume 0.96M

Average 1.24M

Private 5-step workspace

Build a RGNX investment thesis

Turn REGENXBIO Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.